BCH294 (with others, spring semesters)
BCH482 Biochemistry (every spring semester)
BCH561 RNA Structure and Function (every semester)
BCH584 Nucleic Acids (fall semesters- odd numbered years)
BCH380 Fundamentals of Biochemistry (fall semesters- even numbered years)
The overall research focus of my group is viral RNA structure and function, including RNA-protein, RNA-RNA, and RNA-small molecule interactions. Our study system is Rift Valley fever virus. Specifically, we investigate the roles of RNA structural motifs within the viral genomes and mRNAs in the processes of viral packaging, translation, and splicing. Inhibition of any of these essential processes represents a potential antiviral therapeutic approach.
B.S. Chemistry, University of Montana 1985
M.S. Biochemistry, University of Montana, 1991
Ph.D. Biology, Brown University, 1996
My research interests lie in the mechanisms of molecular recognition between biological macromolecules. In particular, I am interested in RNA-RNA and RNA-protein interactions as they relate to viral replication. Interfering with these essential interactions during viral replication represents a potential avenue for antiviral drug development.
Rift Valley fever virus (RVFV) is a mosquito borne pathogen that is endemic to Africa, but has the potential for spread outside its historical boundaries due to increased global trade and changing climate patterns. The virus causes disease in humans and livestock. In humans, symptoms range from a mild flu-like illness to severe hemorrhagic fever. So far there are no proven treatments or vaccines to combat or prevent the disease.
RVFV nucleocapsid protein, N, has several known functions during replication, including roles in encapsidation, packaging, translational control, and regulating the balance between genomic and antigenomic viral RNA synthesis in infected cells. Each of these functions is crucial for the virus to propagate successfully and each involves interactions with RNA. We are striving to understand at the molecular level how N recognizes viral RNA. We are also endeavoring to identify small molecule inhibitors of this interaction that could be developed into drugs to treat humans and/or livestock that are infected with RVFV.
Field of Study
Molecular virology and RNA biochemistry
Ellenbecker, M, St Goddard, J, Sundet, A, Lanchy, JM,Raiford, D, Lodmell, JS (2015) Computational prediction and biochemical characterization of novel RNA aptamers to Rift Valley fever virus nucleocapsid protein. Comput Biol Chem, 58, 120-5.
Ellenbecker, M, Lanchy, JM, Lodmell, JS (2014) Inhibition of Rift Valley fever virus replication and perturbation of nucleocapsid-RNA interactions by suramin. Antimicrob Agents Chemother, 58, (12), 7405-15.
Ellenbecker M, Lanchy JM, Lodmell JS (2012) Identification of Rift Valley fever virus nucleocapsid protein-RNA binding inhibitors using a high-throughput screening assay. Journal of biomolecular screening 17: 1062-1070. PMCID: PMC3520603.
Ellenbecker M, Sears L, Li P, Lanchy JM, Lodmell JS (2012) Characterization of RNA aptamers directed against the nucleocapsid protein of Rift Valley fever virus. Antiviral Res 93: 330-339. PMCID: PMC3299919.
Wright BE, Schmidt KH, Hunt AT, Lodmell JS, Minnick MF, Reschke DK (2011) The roles of transcription and genotoxins underlying p53 mutagenesis in vivo. Carcinogenesis 32: 1559-1567. PMCID: PMC3179427.
Strong CL, Lanchy JM, Lodmell JS. Viral SELEX reveals individual and cooperative roles of the C-box and G-box in HIV-2 replication. RNA. 2011;17(7):1307-20. PMCID: 3138567.
Strong CL, Lanchy JM, Dieng-Sarr A, Kanki PJ, Lodmell JS. A 5'UTR-Spliced mRNA Isoform Is Specialized for Enhanced HIV-2 gag Translation. J Mol Biol. 2009;391(2):426-37. PMCID: PMC2750851.
Baig TT, Lanchy JM, Lodmell JS. Randomization and in vivo selection reveal a GGRG motif essential for packaging human immunodeficiency virus type 2 RNA. J Virol. 2009;83(2):802-10. PMCID: PMC2612376.
Baig TT, Strong CL, Lodmell JS, Lanchy JM. Regulation of primate lentiviral RNA dimerization by structural entrapment. Retrovirology. 2008;5:65. PMCID: PMC2494553.
Lanchy JM, Lodmell JS. An extended stem-loop 1 is necessary for human immunodeficiency virus type 2 replication and affects genomic RNA encapsidation. J Virol. 2007;81(7):3285-92. PMCID: PMC1866085.
Fabbretti A, Pon CL, Hennelly SP, Hill WE, Lodmell JS, Gualerzi CO. The real-time path of translation factor IF3 onto and off the ribosome. Mol Cell. 2007;25(2):285-96.
Baig TT, Lanchy JM, Lodmell JS. HIV-2 RNA dimerization is regulated by intramolecular interactions in vitro. RNA. 2007;13(8):1341-54. PMCID: PMC1924897.
Criswell D, Tobiason VL, Lodmell JS, Samuels DS. Mutations conferring aminoglycoside and spectinomycin resistance in Borrelia burgdorferi. Antimicrob Agents Chemother. 2006;50(2):445-52. PMCID: PMC1366916.
Knight W, Hill W, Lodmell JS. Ribosome builder: a software project to simulate the ribosome. Comput Biol Chem. 2005;29(2):163-74.
Hennelly SP, Antoun A, Ehrenberg M, Gualerzi CO, Knight W, Lodmell JS, et al. A time-resolved investigation of ribosomal subunit association. J Mol Biol. 2005;346(5):1243-58.
Bowen WS, Van Dyke N, Murgola EJ, Lodmell JS, Hill WE. Interaction of thiostrepton and elongation factor-G with the ribosomal protein L11-binding domain. J Biol Chem. 2005;280(4):2934-43.
RNASocietyNews. Annual RNA/Scaringe Award Presented to Stefano Marzi. RNA. 2004;10(8):1036.
Lanchy JM, Szafran QN, Lodmell JS. Splicing affects presentation of RNA dimerization signals in HIV-2 in vitro. Nucleic Acids Res. 2004;32(15):4585-95. PMCID: PMC516069.
Brandi L, Marzi S, Fabbretti A, Fleischer C, Hill WE, Gualerzi CO, et al. The translation initiation functions of IF2: targets for thiostrepton inhibition. J Mol Biol. 2004;335(4):881-94.
Marzi S, Knight W, Brandi L, Caserta E, Soboleva N, Hill WE, et al. Ribosomal localization of translation initiation factor IF2. RNA. 2003;9(8):958-69. PMCID: PMC1370462.
Lodmell JS, Hennelly SP. Conformational dynamics within the ribosome. In: Lapointe J, Brakier-Gingras L, editors. Translation Mechanisms. Georgetown, TX USA: Kluwer Academic/ Plenum Publishers; 2003. p. 264-79.
Lanchy JM, Rentz CA, Ivanovitch JD, Lodmell JS. Elements located upstream and downstream of the major splice donor site influence the ability of HIV-2 leader RNA to dimerize in vitro. Biochemistry. 2003;42(9):2634-42. PMCID: PMC1473984.
Lanchy JM, Ivanovitch JD, Lodmell JS. A structural linkage between the dimerization and encapsidation signals in HIV-2 leader RNA. RNA. 2003;9(8):1007-18. PMCID: PMC1370466.
Deer EL, Douk B, Lanchy JM, Lodmell JS. Elucidation and characterization of oligonucleotide-accessible sites on HIV-2 leader region RNA. Antisense Nucleic Acid Drug Dev. 2003;13(1):45-55. PMCID: PMC1403296.
Lanchy JM, Lodmell JS. Alternate usage of two dimerization initiation sites in HIV-2 viral RNA in vitro. J Mol Biol. 2002;319(3):637-48. PMCID: PMC1451413.
Lodmell JS, Ehresmann C, Ehresmann B, Marquet R. Structure and dimerization of HIV-1 kissing loop aptamers. J Mol Biol. 2001;311(3):475-90.
Jossinet F, Lodmell JS, Ehresmann C, Ehresmann B, Marquet R. Identification of the in vitro HIV-2/SIV RNA dimerization site reveals striking differences with HIV-1. J Biol Chem. 2001;276(8):5598-604.
Bowen WS, Hill WE, Lodmell JS. Comparison of rRNA cleavage by complementary 1,10-phenanthroline-Cu(II)- and EDTA-Fe(II)-derivatized oligonucleotides. Methods. 2001;25(3):344-50.
Lodmell JS, Ehresmann C, Ehresmann B, Marquet R. Convergence of natural and artificial evolution on an RNA loop-loop interaction: the HIV-1 dimerization initiation site. RNA. 2000;6(9):1267-76. PMCID: PMC1370000.
Jossinet F, Paillart JC, Westhof E, Hermann T, Skripkin E, Lodmell JS, et al. Dimerization of HIV-1 genomic RNA of subtypes A and B: RNA loop structure and magnesium binding. RNA. 1999;5(9):1222-34. PMCID: PMC1369845.
Lodmell JS, Paillart JC, Mignot D, Ehresmann B, Ehresmann C, Marquet R. Oligonucleotide-mediated inhibition of genomic RNA dimerization of HIV-1 strains MAL and LAI: a comparative analysis. Antisense Nucleic Acid Drug Dev. 1998;8(6):517-29.
Gregory ST, Brunelli CA, Lodmell JS, O'Connor M, Dahlberg AE. Genetic selection of rRNA mutations. Methods Mol Biol. 1998;77:271-81.
Lodmell JS, Dahlberg AE. A conformational switch in Escherichia coli 16S ribosomal RNA during decoding of messenger RNA. Science. 1997;277(5330):1262-7.
O'Connor M, Brunelli CA, Firpo MA, Gregory ST, Lieberman KR, Lodmell JS, et al. Genetic probes of ribosomal RNA function. Biochem Cell Biol. 1995;73(11-12):859-68.
Lodmell JS, Gutell RR, Dahlberg AE. Genetic and comparative analyses reveal an alternative secondary structure in the region of nt 912 of Escherichia coli 16S rRNA. Proc Natl Acad Sci U S A. 1995;92(23):10555-9. PMCID: PMC40650.
Lodmell JS, Tapprich WE, Hill WE. Evidence for a conformational change in the exit site of the Escherichia coli ribosome upon tRNA binding. Biochemistry. 1993;32(15):4067-72.
Marconi RT, Lodmell JS, Hill WE. Identification of a rRNA/chloramphenicol interaction site within the peptidyltransferase center of the 50 S subunit of the Escherichia coli ribosome. J Biol Chem. 1990;265(14):7894-9.
Viral RNA structure and function
Division of Biological Sciences
Specialized Research Interests
The roles RNA structure and RNA-protein interactions in the regulation of viral replication and gene expression.
Area of Expertise
Molecular Virology; RNA Biochemistry
Post-doctoral Fellow 1996-1999
Institut de Biologie Moléculaire et Cellulaire
CNRS UPR 9002
Université Louis Pasteur
Visiting Scholar 2006-2007
(Research on Rift Valley fever virus N-RNA interactions, hosted by Prof. Richard Elliott)
The University of St. Andrews
Centre for Biomolecular Sciences
St. Andrews, UK
Visiting Professor June-August 2011
(Research on ribosome structure and function, hosted by Prof. Albert Dahlberg)